Market Overview:
The global vitreoretinal surgery device market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye disorders, rising geriatric population, and technological advancements in vitreoretinal surgery devices. Based on type, the global vitreoretinal surgery device market is segmented into vitrectomy machines & packs, photocoagulation surgery devices, illumination devices, and others. The vitrectomy machines & packs segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030 due to increasing demand for minimally invasive surgeries and rising awareness about advanced surgical procedures among patients worldwide. Based on application, the global vitreoretinal surgery device market is divided into hospitals, free standing ambulatory surgery centers (ASCs), and others (clinics/private practices).
Product Definition:
A vitreoretinal surgery device is a medical device that is used during vitreoretinal surgery. This type of surgery is used to treat conditions that affect the retina, such as retinal detachment, macular degeneration, and diabetic retinopathy. The vitreoretinal surgery device helps to keep the retina in place and restore its function.
Vitrectomy Machines & Packs:
Vitrectomy machines & packs are used for removing the vitreous gel that occupies a major part of the interior eye. This procedure is performed to cure several retinal disorders including wet age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The increasing prevalence of these disorders globally is expected to drive market growth over the forecast period.
Photocoagulation Surgery Devices:
Photocoagulation surgery devices are used in vitreoretinal surgery. Photocoagulation is a surgical technique that involves the use of laser for treating macular degeneration, retinitis pigmentosa and other retinal diseases. The photocoagulation procedure helps to stimulate new blood vessel growth and aids in shrinking of abnormal blood vessels which reduces the risk of vision loss.
Application Insights:
Based on application, the global vitreoretinal surgery device market is segmented into hospitals, free-standing ambulatory surgical centers, and others. Hospitals held the largest share in 2017 owing to factors such as a high prevalence of diabetes and other retinal diseases in developing countries. Furthermore, increasing awareness about advanced treatment options for diabetic retinopathy is expected to drive demand over the forecast period.
The free-standing ambulatory surgical center segment is anticipated to witness significant growth over the forecast period due to an increase in patients seeking treatment outside of hospital settings due to financial constraints or travel time required for admission will be a major factor deterring patients from seeking timely medical attention resulting in under utilization of vitreoretinal surgery devices at these centers which may hinder market growth during future years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing diabetic retinopathy cases, high adoption of advanced technologies, and presence of major players in this region. Moreover, rising awareness about various treatment options for retinal diseases is expected to fuel the regional market growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding vitreoretinal surgery procedures & associated benefits. In addition, increasing prevalence of diabetes is also likely to contribute towards regional demand for these devices during the same period (8% - 11% increase per year). Growing medical tourism industry in emerging economies such as India & China are further expected boost product penetration rates across this region over next eight years (2018-2030).
Growth Factors:
- Increasing prevalence of eye disorders and blindness: The increasing prevalence of various eye disorders, such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma is expected to drive the demand for vitreoretinal surgery devices over the forecast period. According to the World Health Organization (WHO), around 285 million people are visually impaired worldwide, out of which 39 million are blind. This number is expected to increase due to the growing aging population and rising incidence of chronic diseases such as diabetes.
- Technological advancements in vitreoretinal surgery devices: The technological advancements in vitreoretinal surgery devices are anticipated to boost the growth of this market during the forecast period. For instance, in January 2017, Johnson & Johnson Vision Care announced that it had received FDA approval for its new CentraSight five-treatment program for age-related macular degeneration (AMD). This program uses a miniature telescope implant that is surgically placed inside the eye with a cataract procedure to improve vision in patients with AMD who have lost central vision. Such technological advancements are likely to increase patient compliance rates and drive market growth over the forecast period.
- Rising demand from emerging markets: The Vitreoretinal Surgery Device market is witnessing high growth potential from emerging markets such as India and China owing to increasing awareness about available treatment options coupled with rising disposable incomes among consumers in these regions.. In addition, government initiatives aimed at improving healthcare
Scope Of The Report
Report Attributes
Report Details
Report Title
Vitreoretinal Surgery Device Market Research Report
By Type
Vitrectomy Machines & Packs, Photocoagulation Surgery Devices, Illumination Devices, Others
By Application
Hospitals, Free Standing Ambulatory Surgery Centers, Others
By Companies
Allen Medical Systems, Abbott Laboratories, Medtronic, Mediland Enterprise, Merivaara, Wallach Surgical Devices, Sunnex MedicaLights, Stars Medical Devices, Smith & Nephew, Alcon, MedOne Surgical, Bausch & Lomb, Topcon, Peregrine Surgical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Vitreoretinal Surgery Device Market Report Segments:
The global Vitreoretinal Surgery Device market is segmented on the basis of:
Types
Vitrectomy Machines & Packs, Photocoagulation Surgery Devices, Illumination Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Free Standing Ambulatory Surgery Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allen Medical Systems
- Abbott Laboratories
- Medtronic
- Mediland Enterprise
- Merivaara
- Wallach Surgical Devices
- Sunnex MedicaLights
- Stars Medical Devices
- Smith & Nephew
- Alcon
- MedOne Surgical
- Bausch & Lomb
- Topcon
- Peregrine Surgical
Highlights of The Vitreoretinal Surgery Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vitrectomy Machines & Packs
- Photocoagulation Surgery Devices
- Illumination Devices
- Others
- By Application:
- Hospitals
- Free Standing Ambulatory Surgery Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vitreoretinal Surgery Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vitreoretinal surgery device is a medical device that is inserted into the eye to correct vision problems. This type of surgery can be used to treat conditions such as macular degeneration, diabetic retinopathy, and glaucoma.
Some of the major companies in the vitreoretinal surgery device market are Allen Medical Systems, Abbott Laboratories, Medtronic, Mediland Enterprise, Merivaara, Wallach Surgical Devices, Sunnex MedicaLights, Stars Medical Devices, Smith & Nephew, Alcon, MedOne Surgical, Bausch & Lomb, Topcon, Peregrine Surgical.
The vitreoretinal surgery device market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vitreoretinal Surgery Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vitreoretinal Surgery Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vitreoretinal Surgery Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vitreoretinal Surgery Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vitreoretinal Surgery Device Market Size & Forecast, 2018-2028
4.5.1 Vitreoretinal Surgery Device Market Size and Y-o-Y Growth
4.5.2 Vitreoretinal Surgery Device Market Absolute $ Opportunity
Chapter 5 Global Vitreoretinal Surgery Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Vitreoretinal Surgery Device Market Size Forecast by Type
5.2.1 Vitrectomy Machines & Packs
5.2.2 Photocoagulation Surgery Devices
5.2.3 Illumination Devices
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Vitreoretinal Surgery Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Vitreoretinal Surgery Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Free Standing Ambulatory Surgery Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vitreoretinal Surgery Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vitreoretinal Surgery Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Vitreoretinal Surgery Device Analysis and Forecast
9.1 Introduction
9.2 North America Vitreoretinal Surgery Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Vitreoretinal Surgery Device Market Size Forecast by Type
9.6.1 Vitrectomy Machines & Packs
9.6.2 Photocoagulation Surgery Devices
9.6.3 Illumination Devices
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Vitreoretinal Surgery Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Free Standing Ambulatory Surgery Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Vitreoretinal Surgery Device Analysis and Forecast
10.1 Introduction
10.2 Europe Vitreoretinal Surgery Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Vitreoretinal Surgery Device Market Size Forecast by Type
10.6.1 Vitrectomy Machines & Packs
10.6.2 Photocoagulation Surgery Devices
10.6.3 Illumination Devices
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Vitreoretinal Surgery Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Free Standing Ambulatory Surgery Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Vitreoretinal Surgery Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Vitreoretinal Surgery Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Vitreoretinal Surgery Device Market Size Forecast by Type
11.6.1 Vitrectomy Machines & Packs
11.6.2 Photocoagulation Surgery Devices
11.6.3 Illumination Devices
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Vitreoretinal Surgery Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Free Standing Ambulatory Surgery Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Vitreoretinal Surgery Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Vitreoretinal Surgery Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Vitreoretinal Surgery Device Market Size Forecast by Type
12.6.1 Vitrectomy Machines & Packs
12.6.2 Photocoagulation Surgery Devices
12.6.3 Illumination Devices
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Vitreoretinal Surgery Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Free Standing Ambulatory Surgery Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Vitreoretinal Surgery Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Vitreoretinal Surgery Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Vitreoretinal Surgery Device Market Size Forecast by Type
13.6.1 Vitrectomy Machines & Packs
13.6.2 Photocoagulation Surgery Devices
13.6.3 Illumination Devices
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Vitreoretinal Surgery Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Free Standing Ambulatory Surgery Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vitreoretinal Surgery Device Market: Competitive Dashboard
14.2 Global Vitreoretinal Surgery Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allen Medical Systems
14.3.2 Abbott Laboratories
14.3.3 Medtronic
14.3.4 Mediland Enterprise
14.3.5 Merivaara
14.3.6 Wallach Surgical Devices
14.3.7 Sunnex MedicaLights
14.3.8 Stars Medical Devices
14.3.9 Smith & Nephew
14.3.10 Alcon
14.3.11 MedOne Surgical
14.3.12 Bausch & Lomb
14.3.13 Topcon
14.3.14 Peregrine Surgical
